がん支持療法製品の世界市場レポート 2025年

がん支持療法製品の市場規模は、今後数年間で安定した成長が見込まれます。2029年にはCAGR4.8％で273億2,000万米ドルに成長します。予測期間の成長は、がんの有病率の上昇、患者中心のアプローチの増加、がん研究への投資の増加、個別化医療への注目の高まり、がん生存率の上昇に起因すると考えられます。予測期間における主な動向としては、技術の進歩、先進ドラッグデリバリーシステム、新薬製剤、個別化医療、生分解性製品の開発などが挙げられます。

がんの罹患率の増加は、今後のがん支持療法製品市場の拡大を牽引すると予想されます。人口の高齢化に伴い、細胞の変化や様々な危険因子に長期間さらされることにより、がんのリスクが高まる。さらに、喫煙、食生活の乱れ、運動不足、過度のアルコール摂取などのライフスタイル要因も、がんリスクに大きく寄与しています。がん支持療法製品は、症状を管理し、生活の質を高め、治療中の患者をサポートするように設計されており、がん罹患率の上昇によるニーズの高まりに対応しています。例えば、2024年1月、米国を拠点にがん撲滅に取り組む非営利団体である米国がん協会は、口腔・咽頭がんの罹患者数を5万8,450人と予測し、2023年に報告された5万4,540人から7.2％増加するとしています。その結果、がん罹患率の上昇ががん支持療法製品市場の成長を促進すると予想されます。

がん支持療法製品市場の主要企業は、治療効果の向上、副作用の軽減、患者の転帰の改善を目的に、標的放射性リガンド療法（RLT）プラットフォームなどのイノベーションに取り組んでいます。RLTプラットフォームは、がん細胞マーカーに特異的に結合する放射性標識分子を使用して標的放射線を照射し、健康な組織を温存しながらがん細胞を破壊します。例えば、2022年5月、スイスの製薬会社ノバルティスAGは、これまでの治療に反応しなかった前立腺特異的膜抗原陽性の転移性去勢抵抗性前立腺がん（PSMA陽性mCRPC）の治療薬として、Pluvicto（lutetium Lu 177 vipivotide tetraxetan）のFDA承認を取得しました。プルビクトは、FDAが承認した初めての放射性同位元素標的治療薬であり、標的リガンドと治療用放射性同位元素を組み合わせたものです。さらにFDAは、PET検査でPSMA陽性病変を検出するために使用されるLocametz（ガリウムGa68ゴゼトチド注射剤）を承認しており、がんの拡がりの同定とPluvicto治療の適否の判断に役立っています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界がん支持療法製品 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のがん支持療法製品市場：成長率分析
• 世界のがん支持療法製品市場の実績：規模と成長, 2019-2024
• 世界のがん支持療法製品市場の予測：規模と成長, 2024-2029, 2034F
• 世界がん支持療法製品総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のがん支持療法製品市場薬剤クラス別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 非ステロイド性抗炎症薬
• 抗感染
• 制吐剤
• モノクローナル抗体
• エリスロポエチン刺激剤
• オピオイド鎮痛薬
• ビスホスホネート
• 顆粒球コロニー刺激因子
• 世界のがん支持療法製品市場適応症別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 肺がん
• 乳がん
• 前立腺がん
• 肝臓がん
• 膀胱がん
• 白血病
• 卵巣がん
• メラノーマがん
• その他の適応症
• 世界のがん支持療法製品市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• 調剤薬局
• 世界のがん支持療法製品市場非ステロイド性抗炎症薬（NSAIDs）の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• イブプロフェン
• アスピリン
• ナプロキセン
• 世界のがん支持療法製品市場、抗感染薬のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗生物質
• 抗真菌薬
• 抗ウイルス薬
• 世界のがん支持療法製品市場制吐剤の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 5-HT3拮抗薬（オンダンセトロン）
• Nk1拮抗薬（アプレピタント）
• コルチコステロイド（デキサメタゾン）
• 世界のがん支持療法製品市場モノクローナル抗体の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• リツキシマブ
• トラスツズマブ
• ベバシズマブ
• 世界のがん支持療法製品市場エリスロポエチン刺激剤の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• エポエチンアルファ
• ダルベポエチンアルファ
• 世界のがん支持療法製品市場オピオイド鎮痛剤の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• モルヒネ
• フェンタニル
• オキシコドン
• 世界のがん支持療法製品市場ビスホスホネートの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ゾレドロン酸
• パミドロン酸
• イバンドロネート
• 世界のがん支持療法製品市場顆粒球コロニー刺激因子のサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• フィルグラスチム
• ペグフィルグラスチム

第7章 地域別・国別分析

• 世界のがん支持療法製品市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のがん支持療法製品市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• がん支持療法製品市場：競合情勢
• がん支持療法製品市場：企業プロファイル
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Abbott Laboratories
• Novartis AG
• GlaxoSmithKline plc
• Amgen Inc.
• Becton Dickinson and Company
• Teva Pharmaceutical Industries Limited
• Baxter International Inc.
• Daiichi Sankyo Company Limited
• Agilent Technologies Inc.
• Hologic Inc.
• Illumina Inc.
• Kyowa Hakko Kirin Co. Ltd.
• QIAGEN N.V.
• Exelixis Inc.
• Fagron Group B.V.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• がん支持療法製品市場2029：新たな機会を提供する国
• がん支持療法製品市場2029：新たな機会を提供するセグメント
• がん支持療法製品市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Cancer supportive care products encompass a range of medical treatments, therapies, and products designed to manage and alleviate the symptoms, side effects, and complications associated with cancer and its treatments. These products aim to enhance the quality of life for cancer patients by providing physical, emotional, and psychological support.

Key categories of drugs in cancer supportive care include nonsteroidal anti-inflammatory drugs (NSAIDs), anti-infective drugs, anti-emetics, monoclonal antibodies, erythropoietin-stimulating agents, opioid analgesics, bisphosphonates, and granulocyte colony-stimulating factors. NSAIDs, for example, help reduce inflammation, pain, and fever by inhibiting enzymes involved in the inflammatory process, which assists in managing pain and discomfort related to cancer and its treatments. These products are used for various types of cancer, including lung, breast, prostate, liver, bladder, leukemia, ovarian, and melanoma cancers. They are distributed through hospital pharmacies, retail pharmacies, and compounding pharmacies.

The cancer supportive care products market research report is one of a series of new reports from the business research company that provides cancer supportive care products market statistics, including cancer supportive care products industry global market size, regional shares, competitors with an cancer supportive care products market share, detailed cancer supportive care products market segments, market trends and opportunities, and any further data you may need to thrive in the cancer supportive care products industry. This cancer supportive care products market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cancer supportive care products market size has grown strongly in recent years. It will grow from $21.56 billion in 2024 to $22.65 billion in 2025 at a compound annual growth rate (CAGR) of 5.1%. The growth in the historic period can be attributed to growing cancer incidence, increased awareness and education, improved healthcare infrastructure, a growing geriatric population, increased awareness, and early detection.

The cancer supportive care products market size is expected to see steady growth in the next few years. It will grow to $27.32 billion in 2029 at a compound annual growth rate (CAGR) of 4.8%. The growth in the forecast period can be attributed to the rising prevalence of cancer, growing patient-centric approaches, growing investment in cancer research, a rising focus on personalized medicine, and rising cancer survival rates. Major trends in the forecast period include technological advancements, advanced drug delivery systems, new drug formulations, personalized care, and the and the development of biodegradable products.

The growing incidence of cancer is expected to drive the expansion of the cancer supportive care products market in the future. As populations age, the risk of cancer increases due to cellular changes and prolonged exposure to various risk factors. Additionally, lifestyle factors such as smoking, poor diet, insufficient physical activity, and excessive alcohol consumption contribute significantly to cancer risk. Cancer supportive care products are designed to manage symptoms, enhance quality of life, and support patients undergoing treatment, addressing the increasing need due to the rising cancer rates. For example, in January 2024, the American Cancer Society, a US-based non-profit organization focused on cancer elimination, projected 58,450 cases of oral cavity and pharynx cancer, marking a 7.2% increase from the 54,540 cases reported in 2023. Consequently, the rising incidence of cancer is expected to propel the growth of the cancer supportive care products market.

Leading companies in the cancer supportive care products market are working on innovations such as targeted radioligand therapy (RLT) platforms to improve treatment effectiveness, reduce side effects, and enhance patient outcomes. RLT platforms use radiolabeled molecules that specifically bind to cancer cell markers to deliver targeted radiation, destroying cancer cells while preserving healthy tissue. For instance, in May 2022, Novartis AG, a Switzerland-based pharmaceutical company, received FDA approval for Pluvicto (lutetium Lu 177 vipivotide tetraxetan) for the treatment of prostate-specific membrane antigen-positive metastatic castration-resistant prostate cancer (PSMA-positive mCRPC) that has not responded to previous treatments. Pluvicto is the first FDA-approved targeted radioligand therapy for this condition, combining a targeting ligand with a therapeutic radioisotope. Additionally, the FDA approved Locametz (gallium Ga 68 gozetotide injection), used in PET scans to detect PSMA-positive lesions, aiding in the identification of cancer spread and determining suitability for Pluvicto treatment.

In October 2023, Eli Lilly and Company, a US-based pharmaceutical firm, acquired POINT Biopharma Global Inc. for an undisclosed sum. This acquisition aims to enhance Eli Lilly's capabilities in targeted radiopharmaceuticals for cancer treatment. POINT Biopharma Global Inc., a US-based biotechnology company, focuses on developing and commercializing radiopharmaceuticals for targeted cancer therapies.

Major companies operating in the cancer supportive care products market are Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Amgen Inc., Becton Dickinson and Company, Teva Pharmaceutical Industries Limited, Baxter International Inc., Daiichi Sankyo Company Limited, Agilent Technologies Inc., Hologic Inc., Illumina Inc., Kyowa Hakko Kirin Co. Ltd., QIAGEN N.V., Exelixis Inc., Fagron Group B.V., Tessa Therapeutics Pte Ltd., Mirati Therapeutics Inc., APR Applied Pharma Science Research S.A., Acacia Pharma Ltd., Arquer Diagnostics Ltd.

North America was the largest region in the cancer supportive care products market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer supportive care products market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cancer supportive care products market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cancer supportive care products market consists of sales of medications, nutritional supplements, pain management products, and therapeutic devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cancer Supportive Care Products Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cancer supportive care products market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cancer supportive care products ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cancer supportive care products market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Drug Class: Nonsteroidal Anti-Inflammatory Drugs; Anti-Infective; Anti-Emetics; Monoclonal Antibodies; Erythropoietin Stimulating Agents; Opioid Analgesics; Bisphosphonates; Granulocyte Colony Stimulating Factor
• 2) By Indication: Lung Cancer; Breast Cancer; Prostate Cancer; Liver Cancer; Bladder Cancer; Leukemia; Ovary Cancer; Melanoma Cancer; Other Indications
• 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Compounding Pharmacies

Subsegments

• 1) By Nonsteroidal Anti-Inflammatory Drugs (Nsaids): Ibuprofen; Aspirin; Naproxen
• 2) By Anti-Infective: Antibiotics; Antifungal Drugs; Antiviral Drugs
• 3) By Anti-Emetics: 5-Ht3 Antagonists (Ondansetron); Nk1 Antagonists (Aprepitant); Corticosteroids (Dexamethasone)
• 4) By Monoclonal Antibodies: Rituximab; Trastuzumab; Bevacizumab
• 5) By Erythropoietin Stimulating Agents: Epoetin Alfa; Darbepoetin Alfa
• 6) By Opioid Analgesics: Morphine; Fentanyl; Oxycodone
• 7) By Bisphosphonates: Zoledronic Acid; Pamidronate; Ibandronate
• 8) By Granulocyte Colony Stimulating Factor: Filgrastim; Pegfilgrastim
• Companies Mentioned: Johnson & Johnson; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; AbbVie Inc.; Bayer AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cancer Supportive Care Products Market Characteristics

3. Cancer Supportive Care Products Market Trends And Strategies

4. Cancer Supportive Care Products Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Cancer Supportive Care Products Growth Analysis And Strategic Analysis Framework

• 5.1. Global Cancer Supportive Care Products PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Cancer Supportive Care Products Market Growth Rate Analysis
• 5.4. Global Cancer Supportive Care Products Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Cancer Supportive Care Products Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Cancer Supportive Care Products Total Addressable Market (TAM)

6. Cancer Supportive Care Products Market Segmentation

• 6.1. Global Cancer Supportive Care Products Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Nonsteroidal Anti-Inflammatory Drugs
• Anti-Infective
• Anti-Emetics
• Monoclonal Antibodies
• Erythropoietin Stimulating Agents
• Opioid Analgesics
• Bisphosphonates
• Granulocyte Colony Stimulating Factor
• 6.2. Global Cancer Supportive Care Products Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Lung Cancer
• Breast Cancer
• Prostate Cancer
• Liver Cancer
• Bladder Cancer
• Leukemia
• Ovary Cancer
• Melanoma Cancer
• Other Indications
• 6.3. Global Cancer Supportive Care Products Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Compounding Pharmacies
• 6.4. Global Cancer Supportive Care Products Market, Sub-Segmentation Of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ibuprofen
• Aspirin
• Naproxen
• 6.5. Global Cancer Supportive Care Products Market, Sub-Segmentation Of Anti-Infective, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antibiotics
• Antifungal Drugs
• Antiviral Drugs
• 6.6. Global Cancer Supportive Care Products Market, Sub-Segmentation Of Anti-Emetics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 5-Ht3 Antagonists (Ondansetron)
• Nk1 Antagonists (Aprepitant)
• Corticosteroids (Dexamethasone)
• 6.7. Global Cancer Supportive Care Products Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Rituximab
• Trastuzumab
• Bevacizumab
• 6.8. Global Cancer Supportive Care Products Market, Sub-Segmentation Of Erythropoietin Stimulating Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Epoetin Alfa
• Darbepoetin Alfa
• 6.9. Global Cancer Supportive Care Products Market, Sub-Segmentation Of Opioid Analgesics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Morphine
• Fentanyl
• Oxycodone
• 6.10. Global Cancer Supportive Care Products Market, Sub-Segmentation Of Bisphosphonates, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Zoledronic Acid
• Pamidronate
• Ibandronate
• 6.11. Global Cancer Supportive Care Products Market, Sub-Segmentation Of Granulocyte Colony Stimulating Factor, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Filgrastim
• Pegfilgrastim

7. Cancer Supportive Care Products Market Regional And Country Analysis

• 7.1. Global Cancer Supportive Care Products Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Cancer Supportive Care Products Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cancer Supportive Care Products Market

• 8.1. Asia-Pacific Cancer Supportive Care Products Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Cancer Supportive Care Products Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Cancer Supportive Care Products Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Cancer Supportive Care Products Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cancer Supportive Care Products Market

• 9.1. China Cancer Supportive Care Products Market Overview
• 9.2. China Cancer Supportive Care Products Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Cancer Supportive Care Products Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Cancer Supportive Care Products Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cancer Supportive Care Products Market

• 10.1. India Cancer Supportive Care Products Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Cancer Supportive Care Products Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Cancer Supportive Care Products Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cancer Supportive Care Products Market

• 11.1. Japan Cancer Supportive Care Products Market Overview
• 11.2. Japan Cancer Supportive Care Products Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Cancer Supportive Care Products Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Cancer Supportive Care Products Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cancer Supportive Care Products Market

• 12.1. Australia Cancer Supportive Care Products Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Cancer Supportive Care Products Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Cancer Supportive Care Products Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cancer Supportive Care Products Market

• 13.1. Indonesia Cancer Supportive Care Products Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Cancer Supportive Care Products Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Cancer Supportive Care Products Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cancer Supportive Care Products Market

• 14.1. South Korea Cancer Supportive Care Products Market Overview
• 14.2. South Korea Cancer Supportive Care Products Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Cancer Supportive Care Products Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Cancer Supportive Care Products Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cancer Supportive Care Products Market

• 15.1. Western Europe Cancer Supportive Care Products Market Overview
• 15.2. Western Europe Cancer Supportive Care Products Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Cancer Supportive Care Products Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Cancer Supportive Care Products Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cancer Supportive Care Products Market

• 16.1. UK Cancer Supportive Care Products Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Cancer Supportive Care Products Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Cancer Supportive Care Products Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cancer Supportive Care Products Market

• 17.1. Germany Cancer Supportive Care Products Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Cancer Supportive Care Products Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Cancer Supportive Care Products Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cancer Supportive Care Products Market

• 18.1. France Cancer Supportive Care Products Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Cancer Supportive Care Products Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Cancer Supportive Care Products Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cancer Supportive Care Products Market

• 19.1. Italy Cancer Supportive Care Products Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Cancer Supportive Care Products Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Cancer Supportive Care Products Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cancer Supportive Care Products Market

• 20.1. Spain Cancer Supportive Care Products Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Cancer Supportive Care Products Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Cancer Supportive Care Products Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cancer Supportive Care Products Market

• 21.1. Eastern Europe Cancer Supportive Care Products Market Overview
• 21.2. Eastern Europe Cancer Supportive Care Products Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Cancer Supportive Care Products Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Cancer Supportive Care Products Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cancer Supportive Care Products Market

• 22.1. Russia Cancer Supportive Care Products Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Cancer Supportive Care Products Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Cancer Supportive Care Products Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cancer Supportive Care Products Market

• 23.1. North America Cancer Supportive Care Products Market Overview
• 23.2. North America Cancer Supportive Care Products Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Cancer Supportive Care Products Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Cancer Supportive Care Products Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cancer Supportive Care Products Market

• 24.1. USA Cancer Supportive Care Products Market Overview
• 24.2. USA Cancer Supportive Care Products Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Cancer Supportive Care Products Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Cancer Supportive Care Products Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cancer Supportive Care Products Market

• 25.1. Canada Cancer Supportive Care Products Market Overview
• 25.2. Canada Cancer Supportive Care Products Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Cancer Supportive Care Products Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Cancer Supportive Care Products Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cancer Supportive Care Products Market

• 26.1. South America Cancer Supportive Care Products Market Overview
• 26.2. South America Cancer Supportive Care Products Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Cancer Supportive Care Products Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Cancer Supportive Care Products Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cancer Supportive Care Products Market

• 27.1. Brazil Cancer Supportive Care Products Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Cancer Supportive Care Products Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Cancer Supportive Care Products Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cancer Supportive Care Products Market

• 28.1. Middle East Cancer Supportive Care Products Market Overview
• 28.2. Middle East Cancer Supportive Care Products Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Cancer Supportive Care Products Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Cancer Supportive Care Products Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cancer Supportive Care Products Market

• 29.1. Africa Cancer Supportive Care Products Market Overview
• 29.2. Africa Cancer Supportive Care Products Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Cancer Supportive Care Products Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Cancer Supportive Care Products Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cancer Supportive Care Products Market Competitive Landscape And Company Profiles

• 30.1. Cancer Supportive Care Products Market Competitive Landscape
• 30.2. Cancer Supportive Care Products Market Company Profiles
  • 30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

31. Cancer Supportive Care Products Market Other Major And Innovative Companies

• 31.1. Abbott Laboratories
• 31.2. Novartis AG
• 31.3. GlaxoSmithKline plc
• 31.4. Amgen Inc.
• 31.5. Becton Dickinson and Company
• 31.6. Teva Pharmaceutical Industries Limited
• 31.7. Baxter International Inc.
• 31.8. Daiichi Sankyo Company Limited
• 31.9. Agilent Technologies Inc.
• 31.10. Hologic Inc.
• 31.11. Illumina Inc.
• 31.12. Kyowa Hakko Kirin Co. Ltd.
• 31.13. QIAGEN N.V.
• 31.14. Exelixis Inc.
• 31.15. Fagron Group B.V.

32. Global Cancer Supportive Care Products Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cancer Supportive Care Products Market

34. Recent Developments In The Cancer Supportive Care Products Market

35. Cancer Supportive Care Products Market High Potential Countries, Segments and Strategies

• 35.1 Cancer Supportive Care Products Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Cancer Supportive Care Products Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Cancer Supportive Care Products Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer